INS and obesity disorder: Our data were in line with Mikłosz et al. (2022), who stated that MSC-Exo-based therapy was sufficient to reduce body fat mass in diet-induced obesity animals and suppress the increase in body weight, which could be related to the promotion of insulin production, improvement of insulin resistance, and regulation of hepatic metabolism.